Advantages and versatility of fluorescence-based methodology to characterize the functionality of LDLR and class mutation assignment.
Ontology highlight
ABSTRACT: Familial hypercholesterolemia (FH) is a common autosomal codominant disease with a frequency of 1:500 individuals in its heterozygous form. The genetic basis of FH is most commonly mutations within the LDLR gene. Assessing the pathogenicity of LDLR variants is particularly important to give a patient a definitive diagnosis of FH. Current studies of LDLR activity ex vivo are based on the analysis of 125I-labeled lipoproteins (reference method) or fluorescent-labelled LDL. The main purpose of this study was to compare the effectiveness of these two methods to assess LDLR functionality in order to validate a functional assay to analyse LDLR mutations. LDLR activity of different variants has been studied by flow cytometry using FITC-labelled LDL and compared with studies performed previously w
SUBMITTER: Etxebarria A
PROVIDER: S-EPMC4227843 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
ACCESS DATA